February 01, 2019
Allergan Inc.'s aggressive bid to block sales of lower-cost compounded drugs has ended with a compounder's agreement to tell customers that its products aren't approved by the U.S. Food and Drug Administration.
January 14, 2019
A California federal judge has rejected Allergan Inc.'s high-stakes effort to make many drug compounding activities unlawful, saying he will defer to the U.S. Food and Drug Administration's decision to allow the activities.
October 22, 2018
Allergan PLC has asked a California federal court to force drug compounders to hand over communications with Ropes & Gray LLP in its suit over alleged copycat drugs, saying the documents lost attorney-client privilege when the compounders sent a memo written by the firm to health care providers assuring them the businesses were legal.
July 17, 2018
Allergan USA Inc. has been awarded nearly $27,300 in sanctions, according to an order in California federal court on Monday, after accusing drug compounders in its suit over copycat drugs of improperly delaying and withholding discovery.
November 27, 2017
Two recently filed lawsuits from Allergan PLC are teeing up a pivotal test of the extent to which drug compounders can mass-produce virtual copies of brand-name prescription drugs, attorneys say.